loader
Please Wait
Applying Filters...

Annual Sales of Daclatasvir reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 654Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Hepatits C Franchise

PharmaCompass
Left Arrow
Right Arrow

01

Brand Name : Hepatits C Franchise

Daclatasvir and Asunaprevir

arrow
Discovery on Target
Not Confirmed

Brand Name : Hepatits C Franchise

arrow
Discovery on Target
Not Confirmed

Daclatasvir and Asunaprevir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2014 Revenue in Millions :

2013 Revenue in Millions :

Growth (%) :

blank

02

Brand Name : Hepatits C Franchise

Daclatasvir and Asunaprevir

arrow
Discovery on Target
Not Confirmed

Brand Name : Hepatits C Franchise

arrow
Discovery on Target
Not Confirmed

Daclatasvir and Asunaprevir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2015 Revenue in Millions : 256

2014 Revenue in Millions : 1,603

Growth (%) : 526%

blank

03

Brand Name : Hepatits C Franchise

Daclatasvir and Asunaprevir

arrow
Discovery on Target
Not Confirmed

Brand Name : Hepatits C Franchise

arrow
Discovery on Target
Not Confirmed

Daclatasvir and Asunaprevir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2017 Revenue in Millions : 406

2016 Revenue in Millions : 1,578

Growth (%) : -74

blank

04

Brand Name : Hepatits C Franchise

Daclatasvir And Asunaprevir

arrow
Discovery on Target
Not Confirmed

Brand Name : Hepatits C Franchise

arrow
Discovery on Target
Not Confirmed

Daclatasvir And Asunaprevir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2016 Revenue in Millions : 1,578

2015 Revenue in Millions : 1,603

Growth (%) : -2

blank

05

Brand Name : Hepatits C Franchise

Daclatasvir And Asunaprevir

arrow
Discovery on Target
Not Confirmed

Brand Name : Hepatits C Franchise

arrow
Discovery on Target
Not Confirmed

Daclatasvir And Asunaprevir

Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

Currency : USD

2018 Revenue in Millions : 17

2017 Revenue in Millions : 406

Growth (%) : -96%

blank